Severe Obstructive Sleep Apnea and Increased Cortical Amyloid-β Deposition.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 21 11 2020
medline: 28 9 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

The suggested association between severe obstructive sleep apnea (OSA) and risk of Alzheimer's disease (AD) needs further study. Only few recent reports exist on associations between brain amyloid-β (Aβ) burden and severe OSA in middle-aged patients. Examine the possible presence of cortical Aβ accumulation in middle-aged patients with severe OSA. We performed detailed multimodal neuroimaging in 19 cognitive intact patients (mean 44.2 years) with severe OSA (Apnea-Hypopnea Index >30 h-1). Known etiological factors for possible Aβ accumulation were used as exclusion criteria. Aβ uptake was studied with [11C]-PiB-PET, glucose metabolism with [18F]-FDG-PET, and structural imaging with 3.0T MRI. When analyzed individually, in [11C]-PiB-PET a substantial number (∼32%) of the patients exhibited statistically significant evidence of increased cortical Aβ uptake based on elevated regional Z-score values, mostly seen bilaterally in the precuneus and posterior cingulum regions. Cortical glucose hypometabolism in [18F]-FDG-PET was seen in two patients. MRI did not show structural changes suggestive of AD-related pathology. Increased [11C]-PiB uptake was seen in middle-aged cognitively intact patients with severe OSA. These findings are similar to those described in cognitive unimpaired older OSA patients. The changes in cortical Aβ uptake suggest that severe OSA itself may predispose to alterations related to AD already in middle-age. Aβ clearance may be compromised without simultaneous evidence of metabolic or structural alterations. The results emphasize the importance of early diagnostics and proper treatment of severe OSA in cognitively intact middle-aged subjects, possibly diminishing the individual risk for later cognitive dysfunction.

Sections du résumé

BACKGROUND
The suggested association between severe obstructive sleep apnea (OSA) and risk of Alzheimer's disease (AD) needs further study. Only few recent reports exist on associations between brain amyloid-β (Aβ) burden and severe OSA in middle-aged patients.
OBJECTIVE
Examine the possible presence of cortical Aβ accumulation in middle-aged patients with severe OSA.
METHODS
We performed detailed multimodal neuroimaging in 19 cognitive intact patients (mean 44.2 years) with severe OSA (Apnea-Hypopnea Index >30 h-1). Known etiological factors for possible Aβ accumulation were used as exclusion criteria. Aβ uptake was studied with [11C]-PiB-PET, glucose metabolism with [18F]-FDG-PET, and structural imaging with 3.0T MRI.
RESULTS
When analyzed individually, in [11C]-PiB-PET a substantial number (∼32%) of the patients exhibited statistically significant evidence of increased cortical Aβ uptake based on elevated regional Z-score values, mostly seen bilaterally in the precuneus and posterior cingulum regions. Cortical glucose hypometabolism in [18F]-FDG-PET was seen in two patients. MRI did not show structural changes suggestive of AD-related pathology.
CONCLUSION
Increased [11C]-PiB uptake was seen in middle-aged cognitively intact patients with severe OSA. These findings are similar to those described in cognitive unimpaired older OSA patients. The changes in cortical Aβ uptake suggest that severe OSA itself may predispose to alterations related to AD already in middle-age. Aβ clearance may be compromised without simultaneous evidence of metabolic or structural alterations. The results emphasize the importance of early diagnostics and proper treatment of severe OSA in cognitively intact middle-aged subjects, possibly diminishing the individual risk for later cognitive dysfunction.

Identifiants

pubmed: 33216027
pii: JAD200736
doi: 10.3233/JAD-200736
doi:

Substances chimiques

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 0
Amyloid beta-Peptides 0
Aniline Compounds 0
Radiopharmaceuticals 0
Thiazoles 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-161

Auteurs

Salla Ylä-Herttuala (S)

Department of Clinical Neurophysiology, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Clinical Neurophysiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Mikko Hakulinen (M)

Department of Clinical Physiology and Nuclear Medicine, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Applied Physics, University of Eastern Finland, Kuopio, Finland.

Pekka Poutiainen (P)

Department of Cyclotron and Radiopharmacy, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.

Tiina M Laitinen (TM)

Department of Clinical Physiology and Nuclear Medicine, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Applied Physics, University of Eastern Finland, Kuopio, Finland.

Anne M Koivisto (AM)

Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Neurosciences, University of Helsinki, Helsinki, Finland.
Department of Geriatrics, Helsinki University Hospital, Helsinki, Finland.

Anne M Remes (AM)

Research Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland.
Medical Research Center, Oulu University Hospital, Oulu, Finland.

Merja Hallikainen (M)

Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Juha-Matti Lehtola (JM)

Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Toni Saari (T)

Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Educational Sciences and Psychology, Philosophical Faculty, University of Eastern Finland, Joensuu, Finland.

Ville Korhonen (V)

Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Mervi Könönen (M)

Department of Clinical Neurophysiology, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Applied Physics, University of Eastern Finland, Kuopio, Finland.
Department of Radiology, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.

Ritva Vanninen (R)

Department of Radiology, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Radiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Hanna Mussalo (H)

Department of Clinical Physiology and Nuclear Medicine, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Clinical Physiology and Nuclear Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Tomi Laitinen (T)

Department of Clinical Physiology and Nuclear Medicine, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Clinical Physiology and Nuclear Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Esa Mervaala (E)

Department of Clinical Neurophysiology, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland.
Department of Clinical Neurophysiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH